COVID-19 after 2 Years from Hospital Discharge : A Pulmonary Function and Chest Computed Tomography Follow-Up Study
© 2024 S. Karger AG, Basel..
INTRODUCTION: Serial follow-up with pulmonary function testing (PFT) and chest computed tomography (CT) after severe COVID-19 are recommended. As a result, many longitudinal studies have been published on COVID-19 of different grade of severity up to 1-year follow-up. Therefore, we aimed at a long-term observational study throughout 2 years after severe COVID-19.
METHODS: Severe COVID-19 patients were consecutively recruited after hospital discharge between March and June 2020 and prospectively followed up for 24 months, with mMRC dyspnea scale and PFT at 6, 12, and 24 months. Chest CT was performed when clinically indicated.
RESULTS: One hundred one patients enrolled completed the observational study. At 24 months, those with reduced total lung capacity (TLC) were 16%, associated with fibrotic ground glass opacity (GGO) and mMRC score >1, respectively, in 75% and 69% of them. At 24 months, those with a reduced diffusing capacity of the lung for CO were 41%, associated with fibrotic GGO and mMRC score >1, respectively, in 53% and 22% of them.
CONCLUSION: Two years after hospitalization for severe COVID-19, a non-negligible number of patients still suffer from "long COVID" due to respiratory damage.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:103 |
|---|---|
| Enthalten in: |
Respiration; international review of thoracic diseases - 103(2024), 1 vom: 18., Seite 22-31 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mennella, Simone [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chest computed tomography |
|---|
| Anmerkungen: |
Date Completed 29.01.2024 Date Revised 29.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1159/000535732 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366855352 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366855352 | ||
| 003 | DE-627 | ||
| 005 | 20240129232055.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000535732 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1274.xml |
| 035 | |a (DE-627)NLM366855352 | ||
| 035 | |a (NLM)38194938 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mennella, Simone |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 after 2 Years from Hospital Discharge |b A Pulmonary Function and Chest Computed Tomography Follow-Up Study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.01.2024 | ||
| 500 | |a Date Revised 29.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 S. Karger AG, Basel. | ||
| 520 | |a INTRODUCTION: Serial follow-up with pulmonary function testing (PFT) and chest computed tomography (CT) after severe COVID-19 are recommended. As a result, many longitudinal studies have been published on COVID-19 of different grade of severity up to 1-year follow-up. Therefore, we aimed at a long-term observational study throughout 2 years after severe COVID-19 | ||
| 520 | |a METHODS: Severe COVID-19 patients were consecutively recruited after hospital discharge between March and June 2020 and prospectively followed up for 24 months, with mMRC dyspnea scale and PFT at 6, 12, and 24 months. Chest CT was performed when clinically indicated | ||
| 520 | |a RESULTS: One hundred one patients enrolled completed the observational study. At 24 months, those with reduced total lung capacity (TLC) were 16%, associated with fibrotic ground glass opacity (GGO) and mMRC score >1, respectively, in 75% and 69% of them. At 24 months, those with a reduced diffusing capacity of the lung for CO were 41%, associated with fibrotic GGO and mMRC score >1, respectively, in 53% and 22% of them | ||
| 520 | |a CONCLUSION: Two years after hospitalization for severe COVID-19, a non-negligible number of patients still suffer from "long COVID" due to respiratory damage | ||
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Chest computed tomography | |
| 650 | 4 | |a Long COVID-19 | |
| 650 | 4 | |a Spirometry | |
| 700 | 1 | |a Alicino, Cristiano |e verfasserin |4 aut | |
| 700 | 1 | |a Anselmo, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Carrega, Giuliana |e verfasserin |4 aut | |
| 700 | 1 | |a Ficarra, Gianluca |e verfasserin |4 aut | |
| 700 | 1 | |a Garra, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Gastaldo, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Gnerre, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Lillo, Flavia |e verfasserin |4 aut | |
| 700 | 1 | |a Tassara, Rodolfo |e verfasserin |4 aut | |
| 700 | 1 | |a Terrile, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Milanese, Manlio |e verfasserin |4 aut | |
| 700 | 0 | |a ACOD Group. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Respiration; international review of thoracic diseases |d 1968 |g 103(2024), 1 vom: 18., Seite 22-31 |w (DE-627)NLM000076384 |x 1423-0356 |7 nnns |
| 773 | 1 | 8 | |g volume:103 |g year:2024 |g number:1 |g day:18 |g pages:22-31 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1159/000535732 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 103 |j 2024 |e 1 |b 18 |h 22-31 | ||